- Pagina principale
- Analisi delle app
- PhlebX MD
- PhlebX MD Vs. Xpedilab Providers
PhlebX MD vs. Xpedilab Providers Utilizzo e statistiche
PhlebX - Laboratory Services
That Come To You
We are providing blood draw services to individuals and organizations, at the comfort of their home, at their community or onsite at their workplace.
We offer same-day service that is available 24-hours a day / 7 days a week, whenever and wherever customers need them.
Our team of registered Phlebotomists and Laboratory partners are fully licensed and certified in their respective states, and adhere to the industry’s highest professional standards.
Our HIPPA-compliant technology platform increases operational efficiency and reliability, while our real-time digital/mobile technology improves significantly response times, cuts down on paperwork and human error rates, and secures patients’ data privacy.
- App Store di Apple
- Gratis
- Salute e fitness
Classifica degli store
- -
The Xpedilab Providers app is the management-side application that allows partners on the Xpedilab platform to organize, assign, and complete blood draws for patients requesting mobile lab testing services.
Administrators can manage their phlebotomy teams’ assignments and schedules using their administrator login and account.
Mobile phlebotomists can see their patient assignments and schedules through their technician login and account, which allows for easy interaction with, and servicing of, patients on the Xpedilab app.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
PhlebX MDRanking a confronto con Xpedilab Providers
Confronta la tendenza di classifica PhlebX MD nei ultimi 28 giorni rispetto a Xpedilab Providers
Rank
Nessun dato disponibile
Classifica PhlebX MD vs. Xpedilab Providers per paese a confronto
Confronta la tendenza di classifica PhlebX MD nei ultimi 28 giorni rispetto a Xpedilab Providers
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
PhlebX MD VS.
Xpedilab Providers
14icembre d, 2024